Gene Symbol:
ABCC8
HGNC:59
Locus Group:
protein-coding gene
Locus Type:
gene with protein product
Location:
11p15.1
Filters:

Ambry Genetics classifications

diabetes mellitus, permanent neonatal 3
Submitted as: OMIM:618857
SD
04/26/2019
Evaluated
03/02/2021
Submitted
hyperinsulinemic hypoglycemia, familial, 1
Submitted as: OMIM:256450
SD
10/12/2015
Evaluated
03/02/2021
Submitted

ClinGen classifications

pulmonary arterial hypertension
AD
10/10/2022
Evaluated
10/18/2023
Submitted
monogenic diabetes
SD
07/24/2022
Evaluated
10/18/2023
Submitted

Genomics England PanelApp classifications

hyperinsulinemic hypoglycemia, familial, 1
Submitted as: OMIM:256450
AD
01/29/2021
Evaluated
03/31/2021
Submitted
diabetes mellitus, permanent neonatal 3
Submitted as: OMIM:618857
AD
02/19/2020
Evaluated
03/31/2021
Submitted
hyperinsulinemic hypoglycemia, familial, 1
Submitted as: OMIM:256450
AR
01/29/2021
Evaluated
03/31/2021
Submitted
diabetes mellitus, permanent neonatal 3
Submitted as: OMIM:618857
AR
02/19/2020
Evaluated
03/31/2021
Submitted
transient neonatal diabetes mellitus
AD
01/29/2021
Evaluated
03/31/2021
Submitted
diabetes mellitus, noninsulin-dependent
Submitted as: OMIM:125853
AD
01/29/2021
Evaluated
03/31/2021
Submitted
diabetes mellitus, transient neonatal, 2
Submitted as: OMIM:610374
Unknown
01/29/2021
Evaluated
03/31/2021
Submitted
hypoglycemia, leucine-induced
Submitted as: OMIM:240800
AD
01/29/2021
Evaluated
03/31/2021
Submitted
permanent neonatal diabetes mellitus
AR
01/29/2021
Evaluated
03/31/2021
Submitted

Illumina classifications

hyperinsulinemic hypoglycemia, familial, 1
AD
03/29/2019
Evaluated
10/15/2020
Submitted

Invitae classifications

diabetes mellitus, transient neonatal, 2
Submitted as: OMIM:610374
AD
10/15/2021
Evaluated
11/30/2023
Submitted
diabetes mellitus, permanent neonatal 3
Submitted as: OMIM:618857
AR
08/25/2023
Evaluated
11/30/2023
Submitted
type 2 diabetes mellitus
Submitted as: OMIM:125853
AD
05/19/2017
Evaluated
11/30/2023
Submitted
hyperinsulinemic hypoglycemia, familial, 1
Submitted as: OMIM:256450
AD
05/26/2023
Evaluated
11/30/2023
Submitted
hyperinsulinemic hypoglycemia, familial, 1
Submitted as: OMIM:256450
AR
05/26/2023
Evaluated
11/30/2023
Submitted

Myriad Women’s Health classifications

Orphanet classifications

maturity-onset diabetes of the young
Submitted as: Orphanet:552
AD
09/14/2021
Evaluated
09/14/2021
Submitted
DEND syndrome
Submitted as: Orphanet:79134
AD
09/14/2021
Evaluated
09/14/2021
Submitted
autosomal recessive hyperinsulinism due to SUR1 deficiency
Submitted as: Orphanet:79643
AR
09/14/2021
Evaluated
09/14/2021
Submitted
permanent neonatal diabetes mellitus
Submitted as: Orphanet:99885
AD
09/14/2021
Evaluated
09/14/2021
Submitted
transient neonatal diabetes mellitus
Submitted as: Orphanet:99886
AD
09/14/2021
Evaluated
09/14/2021
Submitted
autosomal dominant hyperinsulinism due to SUR1 deficiency
Submitted as: Orphanet:276575
AD
09/14/2021
Evaluated
09/14/2021
Submitted
diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency
Submitted as: Orphanet:276598
AD
09/14/2021
Evaluated
09/14/2021
Submitted

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.